Visit our Cancer InDepth Collection for details that go beyond the information in the Fact Sheets.

Size: px
Start display at page:

Download "Visit our Cancer InDepth Collection for details that go beyond the information in the Fact Sheets."

Transcription

1 Conditions and Diseases Cancer En Español (Spanish Version) This collection focuses on conditions related to cancer. These comprehensive and concise factsheets are physician-reviewed and reflect the most current, evidence-based information. Relevant sources are provided for each fact sheet. Visit our Cancer InDepth Collection for details that go beyond the information in the Fact Sheets. En Español (Spanish Version) ABCDEFGHIJKLMNOPQRSTUVWXYZ A B C Acute granulocystic leukemia - child Acute myeloblastic leukemia - child Acute myelogenous leukemia - child Acute myeloid leukemia - child Acute nonlymphoblastic leukemia - child Adrenal cancer Adrenal cortical carcinoma Adrenocortical carcinoma Agranulocytosis AML - child Aphonia Astrocytoma Basal cell carcinoma Benign breast masses Bladder cancer Bone cancer Brain tumor and brain cancer - child Brain tumors Astrocytoma Brain tumor and brain cancer adult Glioblastoma multiforme Breast cancer Breast cysts Cancer fatigue Cancer of the cartilage Cancer of the larynx Cancer of the rectum Cancer of the voicebox Cancer pain syndromes Cancer, endometrial Cancer, nasopharyngeal Cancer, oropharyngeal Cancer, ovarian Cancer, testicular Cancer, throat Cancer, thyroid Page 1 of 6

2 Cancer, tongue Cancer, uterine Cancer Acute lymphoblastic leukemia Acute myelogenous leukemia - adult Astrocytoma Bladder cancer Bone cancer Brain tumor and brain cancer adult Breast cancer Cancer of the adrenal cortex Cervical cancer Chronic lymphocytic leukemia Chronic myelocytic leukemia Colon cancer Endometrial cancer Esophageal cancer Ewing's sarcoma Gallbladder cancer Glioblastoma multiforme Hairy cell leukemia Hodgkin's disease Hodgkin's lymphoma - adult Kaposi's sarcoma Kidney cancer Laryngeal cancer Liver cancer Lung cancer Melanoma Nasopharyngeal cancer Non-Hodgkin's lymphoma in adults Oropharyngeal cancer Osteosarcoma Ovarian cancer Pancreatic cancer Prostate cancer Living with prostate cancer Skin cancer Soft tissue sarcoma Soft tissue sarcoma (alveolar soft part sarcoma) Soft tissue sarcoma (angiosarcoma) Soft tissue sarcoma (dermatofibrosarcoma protuberans) Soft tissue sarcoma (desmoid sarcoma) Soft tissue sarcoma (fibrosarcoma) Soft tissue sarcoma (leiomyosarcoma) Soft tissue sarcoma (liposarcoma) Soft tissue sarcoma (lymphoma [lymphosarcoma]) Soft tissue sarcoma (malignant fibrous histiocytoma) Soft tissue sarcoma (malignant peripheral nerve sheath tumor) Soft tissue sarcoma (rhabdomyosarcoma) Soft tissue sarcoma (synovial sarcoma) Stomach cancer Testicular cancer Throat cancer Thyroid cancer Tongue cancer Uterine cancer Page 2 of 6

3 Vaginal cancer Carcinomas Cartilage cancer Cervical cancer Cervical cancer screening Chondrosarcoma Chronic cystic mastitis Classic whipple Colon cancer Cystic disease E Endometrial adenocarcinoma Endometrial cancer Esophageal achalasia Esophageal cancer Ewing's family of tumors Ewing's family of tumors - child Ewing's sarcoma Ewing's sarcoma - child F Familial adenomatous polyposis Fatigue, cancer G Gallbladder cancer Gastric myoblastoma Gastric myosarcoma Gastrointestinal leiomyosarcoma Gastrointestinal smooth muscle tumor Gastrointestinal stromal sarcoma Gastrointestinal stromal tumor Germinoma GIST Glioblastoma multiforme Glioma Granulocytopenia Granulopenia H Hairy cell leukemia Hepatoma, malignant Hodgkin's disease - child Hodgkin's disease- adult Hodgkin's lymphoma Hodgkin's lymphoma - child I IBC Inflammatory breast cancer Inflammatory breast carcinoma Page 3 of 6

4 Inflammatory carcinoma of the breast Ionizing radiation exposure K Kaposi's sarcoma Kidney cancer L Laryngeal cancer Leukemia - child Leukemia Acute lymphoblastic leukemia Acute myelogenous leukemia Chronic lymphocytic leukemia Chronic myelocytic leukemia Leukemic reticuloendotheliosis Liver cancer Liver cirrhosis Living with prostate cancer Loss of Voice Lymphedema Lymphoma, non-hodgkin's - child Lymphoma Hodgkin's disease- adult Hodgkin's lymphoma - adult Non-Hodgkin's lymphoma in adults M Malignant hepatoma Mammary dysplasia Melanoma Meningioma Mesothelioma pleura Multiple myeloma N Nasopharyngeal cancer Nervous system tumor Neuroblastoma - child Neutropenia Non-hodgkin's lymphoma - child Non-Hodgkin's lymphoma in adults Non-small cell bronchogenic carcinoma Non-small cell lung cancer NSCLC O Oropharyngeal cancer Osteocartilaginous exostosis Osteochondroma Osteogenic sarcoma - child Osteosarcoma Page 4 of 6

5 Osteosarcoma - child Ovarian cancer P Pancreatectomy Pancreatectomy (central pancreatectomy) Pancreatectomy (distal pancreatectomy) Pancreatectomy (total pancreatectomy) Pancreatic cancer Pancreaticoduodenectomy Partial Loss of Voice Peripheral primitive neuroectodermal tumors Peripheral primitive neuroectodermal tumors - child Pituitary adenoma Pituitary tumor Plasma-cell myeloma Pleural mesothelioma PNET PNET - child Primary Lymphedema Prostate cancer Living with prostate cancer R Radiation exposure Rectal cancer Rhabdomyosarcoma - child S Sarcoma, osteogenic - child Seconary Lymphedema Seminoma Skin cancer-basal cell Skin cancer Carcinomas Melanoma Skin cancer-squamos cell Soft tissue sarcoma Soft tissue sarcoma (alveolar soft part sarcoma) Soft tissue sarcoma (angiosarcoma) Soft tissue sarcoma (dermatofibrosarcoma protuberans) Soft tissue sarcoma (desmoid sarcoma) Soft tissue sarcoma (fibrosarcoma) Soft tissue sarcoma (leiomyosarcoma) Soft tissue sarcoma (liposarcoma) Soft tissue sarcoma (lymphoma [lymphosarcoma]) Soft tissue sarcoma (malignant fibrous histiocytoma) Soft tissue sarcoma (malignant peripheral nerve sheath tumor) Soft tissue sarcoma (rhabdomyosarcoma) Soft tissue sarcoma (synovial sarcoma) Squamous cell carcinoma Stomach cancer T Page 5 of 6

6 Testicular cancer Throat cancer Thyroid cancer Tongue cancer Tumor, gastrointestinal stromal U Uterine cancer V Vaginal cancer Voice, loss of Voice, partial loss of W Whipple procedure Whipple procedure (pp whipple) Whipple procedure (pylorus-preserving pancreaticoduodenectomy) Whipple procedure (pylorus-preserving whipple procedure) Wilms' tumor Page 6 of 6

MODERN IMMUNOHISTOCHEMISTRY

MODERN IMMUNOHISTOCHEMISTRY MODERN IMMUNOHISTOCHEMISTRY Cambridge Illustrated Surgical Pathology Peiguo G. Chu City of Hope National Medical Center, Duarte, California Lawrence M. Weiss City of Hope National Medical Center, Duarte,

More information

Part I: NCCN Practice Guidelines Tabular Summary (DD 3/20/13) PET and PET/CT

Part I: NCCN Practice Guidelines Tabular Summary (DD 3/20/13) PET and PET/CT Part I: NCCN Practice Guidelines Tabular Summary (DD 3/20/13) PET and NCCN guidelines were reviewed on 3/20/2013 for utilization of PET and (available at: http://www.nccn.org/professionals/physician_gls/f_guidelines.asp).

More information

Index. F Factor VIII-related antigen, see VWF FactorXIIIa, for dermatofibroma, 272-275 5-HT, see Serotonin

Index. F Factor VIII-related antigen, see VWF FactorXIIIa, for dermatofibroma, 272-275 5-HT, see Serotonin A Acantholytic squamous cell carcinoma vs epithelioid angiosarcoma, 56-57 Acinic cell carcinoma of pancreas, 76-77 vs ductal adenocarcinoma, 74-75 vs islet cell tumor, 78-81 Adenomatoid tumor vs hemangioma,

More information

This module consists of four units which will provide the user a basic knowledge of cancer as a disease.

This module consists of four units which will provide the user a basic knowledge of cancer as a disease. Module 5: What is Cancer? This module consists of four units which will provide the user a basic knowledge of cancer as a disease. After completing this module, cancer abstractors will be able to: Define

More information

4/15/2013. bi/o carcin/ chem/o immun/o onc/o radi/o sarc/o. anabrachydysectoendoneo- -ectomy -genesis -oma -plasia -sarcoma

4/15/2013. bi/o carcin/ chem/o immun/o onc/o radi/o sarc/o. anabrachydysectoendoneo- -ectomy -genesis -oma -plasia -sarcoma Chapter Sixteen Oncology bi/o carcin/ chem/o immun/o onc/o radi/o sarc/o Combining Forms Prefixes and Suffixes Carcinogenesis anabrachydysectoendoneo- -ectomy -genesis -oma -plasia -sarcoma Causes of cancer

More information

Contents. 1. Introduction and Approach to Fine Needle Aspiration Cytology... 1. 2. Head, Neck, Orbit and Salivary Glands... 12

Contents. 1. Introduction and Approach to Fine Needle Aspiration Cytology... 1. 2. Head, Neck, Orbit and Salivary Glands... 12 Contents 1. Introduction and Approach to Fine Needle Aspiration Cytology... 1 Complications 1 Fine Needle Aspiration Technique 1 Evaluation of FNAC Smear 4 Cell Morphology 4 Nucleus 4 Cytoplasm 6 Background

More information

An Introduction to Cancer and Basic Cancer Vocabulary

An Introduction to Cancer and Basic Cancer Vocabulary An Introduction to Cancer and Basic Cancer Vocabulary Marc B. Garnick, MD Beth Israel Deaconess Medical Center Harvard Medical School, Boston Medical Director Cancer Programs Northeast Hospital Corporation,

More information

杏醫有限公司 GINKGOMED COMPANY. Formalin Preserved Pathology Specimens

杏醫有限公司 GINKGOMED COMPANY. Formalin Preserved Pathology Specimens Formalin Preserved Pathology Specimens Since pathology specimens are collected by chance, we will only provide what have already been kept in stock. Formalin-preserved specimens will be mounted on acrylic

More information

CLASSIFICATION OF TUMORS,DIFFERENCE BETWEEN BENIGN AND MALIGNANT TUMORS LEARNING OBJECTIVES

CLASSIFICATION OF TUMORS,DIFFERENCE BETWEEN BENIGN AND MALIGNANT TUMORS LEARNING OBJECTIVES CLASSIFICATION OF TUMORS,DIFFERENCE BETWEEN BENIGN AND MALIGNANT TUMORS LEARNING OBJECTIVES At the end of lectures students should be able to know: Classification of tumors. Difference between benign and

More information

MOH Policy for dispensing NEOPLASTIC DISEASES DRUGS

MOH Policy for dispensing NEOPLASTIC DISEASES DRUGS MOH Policy for dispensing NEOPLASTIC DISEASES DRUGS All prescriptions for antineoplastic drugs must be accompanied by the MOH special form. All the attachments mentioned on this form shall be submitted

More information

David Feltl, M.D., Ph.D., MBA. Structure and organization of cancer care in the Czech Republic. Assessment of outputs and outcomes.

David Feltl, M.D., Ph.D., MBA. Structure and organization of cancer care in the Czech Republic. Assessment of outputs and outcomes. David Feltl, M.D., Ph.D., MBA Structure and organization of cancer care in the Czech Republic. Assessment of outputs and outcomes. Contents Cancer epidemiology in the Czech Republic National oncology program

More information

New Hampshire Childhood Cancer

New Hampshire Childhood Cancer Introduction: New Hampshire Childhood Cancer New Hampshire, Childhood Cancer, January 2009 Issue Brief Cancer in children is relatively uncommon, impacting fewer than twenty two of every 100,000 children

More information

Chapter I Overview Chapter Contents

Chapter I Overview Chapter Contents Chapter I Overview Chapter Contents Table Number Contents I-1 Estimated New Cancer Cases and Deaths for 2005 I-2 53-Year Trends in US Cancer Death Rates I-3 Summary of Changes in Cancer Incidence and Mortality

More information

cancers linked to the development of second cancers

cancers linked to the development of second cancers cancers linked to the development of second cancers No matter what type of cancer is treated, treatments such as radiation and chemotherapy can lead to a second cancer in the long run. Because it can take

More information

Efficient Tumor Immunohistochemistry A Differential Diagnosis-Driven Approach

Efficient Tumor Immunohistochemistry A Differential Diagnosis-Driven Approach Efficient Tumor Immunohistochemistry A Differential Diagnosis-Driven Approach Publishing Team Erik Tanck (production manager/designer) Joshua Weikersheimer (publisher) Copyright 2006 by the American Society

More information

Immunohistochemistry of soft tissue tumors

Immunohistochemistry of soft tissue tumors Immunohistochemistry of soft tissue tumors Immunohistochemistry Major advances : antigen retrieval techniques (HIER) sensitive detection systems numerous antibodies of good quality Standardization : automated

More information

BRAIN TUMOUR RESEARCH FUNDING FLOWS

BRAIN TUMOUR RESEARCH FUNDING FLOWS BRAIN TUMOUR RESEARCH FUNDING FLOWS Ellen Harries, Iona Joy v London, April 2013 (updated) CONTENTS 1 Research brief and headline findings 2 Research funding for cancer 3 Brain tumour funding compared

More information

Co-pay assistance organizations offering assistance

Co-pay assistance organizations offering assistance Acromegaly Acute Exacerbations of Multiple Sclerosis Acute Porphyrias Advanced Idiopathic Parkinson' s Disease Age-Related Macular Degeneration www.theassistancefund.org Alcohol Dependence Alpha-1 Antitrypsin

More information

Introduction: Tumor Swelling / new growth / mass. Two types of growth disorders: Non-Neoplastic. Secondary / adaptation due to other cause.

Introduction: Tumor Swelling / new growth / mass. Two types of growth disorders: Non-Neoplastic. Secondary / adaptation due to other cause. Disorders of Growth Introduction: Tumor Swelling / new growth / mass Two types of growth disorders: Non-Neoplastic Secondary / adaptation due to other cause. Neoplastic. Primary growth abnormality. Non-Neoplastic

More information

Soft Tissue Sarcomas: Questions and Answers

Soft Tissue Sarcomas: Questions and Answers CANCER FACTS N a t i o n a l C a n c e r I n s t i t u t e N a t i o n a l I n s t i t u t e s o f H e a l t h D e p a r t m e n t o f H e a l t h a n d H u m a n S e r v i c e s Soft Tissue Sarcomas:

More information

Cancer and how your policy works. General & Medical

Cancer and how your policy works. General & Medical Cancer and how your policy works General & Medical This booklet, like others in our information book series are designed to help you understand the various aspects of General & Medical private healthcare

More information

Oncology. Objectives. Cancer Nomenclature. Cancer is a disease of the cell Cancer develops when certain cells begin to grow out of control

Oncology. Objectives. Cancer Nomenclature. Cancer is a disease of the cell Cancer develops when certain cells begin to grow out of control Oncology Objectives Describe the etiology and pathophysiological mechanisms of cancer Discuss medical and family history findings relevant to cancer Identify general signs and symptoms associated with

More information

CANCER EXPLAINED. Union for International Cancer Control Union Internationale Contre le Cancer

CANCER EXPLAINED. Union for International Cancer Control Union Internationale Contre le Cancer MEDIA FACTSHEET CANCER EXPLAINED What is cancer? Cancer is a disease which occurs when changes in a group of normal cells within the body lead to uncontrolled growth causing a lump called a tumour; this

More information

Spontaneous Neoplastic Lesions in the CrI:CD-1(ICR) Mouse in Control Groups from 18 Month to 2 year Studies. March, 2005

Spontaneous Neoplastic Lesions in the CrI:CD-1(ICR) Mouse in Control Groups from 18 Month to 2 year Studies. March, 2005 Spontaneous Neoplastic Lesions in the CrI:CD-1(ICR) Mouse in Control Groups from 18 Month to 2 year Studies March, 2005 Information Prepared by Mary L.A. Giknis Ph.D Charles B. Clifford D.V.M, Ph.D TABLE

More information

Immunohistochemical differentiation of metastatic tumours

Immunohistochemical differentiation of metastatic tumours Immunohistochemical differentiation of metastatic tumours Dr Abi Wheal ST1. TERA 3/2/14 Key points from a review article written by Daisuke Nonaka Intro Metastatic disease is the initial presentation in

More information

# Circuits relevant to cancer, related to known TFs.

# Circuits relevant to cancer, related to known TFs. # Circuits relevant to cancer, related to known TFs. # Final dataset of circuits where at least one gene has been annotated as relevant to cancer. # Circuits correspond to blocks separated by a symbol.

More information

Pediatric Oncology for Otolaryngologists

Pediatric Oncology for Otolaryngologists Pediatric Oncology for Otolaryngologists Frederick S. Huang, M.D. Division of Hematology/Oncology Department of Pediatrics The University of Texas Medical Branch Grand Rounds Presentation to Department

More information

Irish Cancer Society Publication Order Form

Irish Cancer Society Publication Order Form Cancer Information Services and Health Promotion/Cancer Prevention TO ORDER PLEASE COMPLETE ALL DETAILS FULLY To help us with information about where the booklets/factsheets are being used please indicate

More information

Special Section Multiple Primary Cancers

Special Section Multiple Primary Cancers Special Section Multiple Primary Cancers Introduction In the past three decades, the development of screening tests that prevent and detect some cancers at an early, more treatable stage, and treatment

More information

NEOPLASMS C00 D49. Presented by Jan Halloran CCS

NEOPLASMS C00 D49. Presented by Jan Halloran CCS NEOPLASMS C00 D49 Presented by Jan Halloran CCS 1 INTRODUCTION A neoplasm is a new or abnormal growth. In the ICD-10-CM classification system, neoplastic disease is classified in categories C00 through

More information

Nuclear Medicine Subgroup. Faculty of Radiologists. Royal College of Surgeons in Ireland INDICATIONS FOR PET/CT IMAGING

Nuclear Medicine Subgroup. Faculty of Radiologists. Royal College of Surgeons in Ireland INDICATIONS FOR PET/CT IMAGING Nuclear Medicine Subgroup Faculty of Radiologists Royal College of Surgeons in Ireland INDICATIONS FOR PET/CT IMAGING Report November 2010 Indications for PET/CT Imaging Bladder Carcinoma Staging for nodal

More information

Friend for Life Cancer Support Network Annual Report 2010. Facing cancer, with someone who s been there

Friend for Life Cancer Support Network Annual Report 2010. Facing cancer, with someone who s been there Friend for Life Cancer Support Network Annual Report 2010 Facing cancer, with someone who s been there This is wonderful support for those of us who are newly diagnosed with cancer. Our Mission To help

More information

Cancer Symptoms Survey. Key Points Summary

Cancer Symptoms Survey. Key Points Summary Cancer Symptoms Survey Key Points Summary March 2012 The Cancer Symptoms Survey has now closed with fieldwork complete. Response rates for each of the 22 cancer groups surveyed are as follows: Sample Size

More information

Hospital-Based Tumor Registry. Srinagarind Hospital, Khon Kaen University

Hospital-Based Tumor Registry. Srinagarind Hospital, Khon Kaen University Hospital-Based Tumor Registry Srinagarind Hospital, Khon Kaen University Statistical Report 2012 Cancer Unit, Faculty of Medicine Khon Kaen University Khon Kaen, Thailand Tel & Fax:+66(43)-202485 E-mail:

More information

A guide to cancer types and chemotherapy medications

A guide to cancer types and chemotherapy medications A guide to cancer types and chemotherapy medications This guides lists words that mean cancer, cancer types and intravenous chemotherapy medications. If you have any questions, see page 10 for details

More information

List of Qualifying Conditions

List of Qualifying Conditions List of Qualifying Conditions Cancer Conditions 1) Adrenal cancer 2) Bladder cancer 3) Bone cancer all forms 4) Brain cancer 5) Breast cancer 6) Cervical cancer 7) Colon cancer 8) Colorectal cancer 9)

More information

MEDICAL POLICY POLICY TITLE

MEDICAL POLICY POLICY TITLE Original Issue Date (Created): July 1, 2002 Most Recent Review Date (Revised): Effective Date: April 15, 2008 July 1, 2009- RETIRED I. DESCRIPTION/BACKGROUND High dose chemotherapy (HDC) involves the administration

More information

Closed Sub-TOI: L08.000 Life - Other Co Tr Num: BANRD-01 State Status: Approved-Closed

Closed Sub-TOI: L08.000 Life - Other Co Tr Num: BANRD-01 State Status: Approved-Closed Project Name/Number: / 01 Filing at a Glance Company: Banner Life Insurance Company SERFF Tr Num: FNBL-126416557 State: Arkansas TOI: L08 Life - Other SERFF Status: Closed-Approved- State Tr Num: 44441

More information

New strategies in anticancer therapy

New strategies in anticancer therapy 癌 症 診 療 指 引 簡 介 及 臨 床 應 用 New strategies in anticancer therapy 中 山 醫 學 大 學 附 設 醫 院 腫 瘤 內 科 蔡 明 宏 醫 師 2014/3/29 Anti-Cancer Therapy Surgical Treatment Radiotherapy Chemotherapy Target Therapy Supportive

More information

Soft tissue sarcoma. For people with cancer, their family and friends

Soft tissue sarcoma. For people with cancer, their family and friends This fact sheet is for people with soft tissue sarcoma who would like to know more about their cancer and its treatment. It describes the types, causes and symptoms of soft tissue sarcoma as well as treatments

More information

Biochemistry of Cancer Cell

Biochemistry of Cancer Cell Biochemistry of Cancer Cell Prof. Taha Kumosani Prof. Taha Kumosani http://biochemistry4all.com/taha/5.htm Cancer: an Overview Paleopathologists Dinosaur bones Egyptians Papyrus Autopsis Hippocrates Carcinoma

More information

NICE guideline Published: 23 June 2015 nice.org.uk/guidance/ng12

NICE guideline Published: 23 June 2015 nice.org.uk/guidance/ng12 Suspected : recognition and referral NICE guideline Published: 23 June 2015 nice.org.uk/guidance/ng12 NICE 2015. All rights reserved. Contents Introduction... 5 Safeguarding children... 6 Patient-centred

More information

Biological Therapies for Cancer

Biological Therapies for Cancer Biological Therapies for Cancer Key Points Biological therapies use the body's immune system to fight cancer or to lessen the side effects that may be caused by some cancer treatments. Biological therapies

More information

The evolving pathology of solitary fibrous tumours. Luciane Dreher Irion MREH / CMFT / NSOPS

The evolving pathology of solitary fibrous tumours. Luciane Dreher Irion MREH / CMFT / NSOPS The evolving pathology of solitary fibrous tumours Luciane Dreher Irion MREH / CMFT / NSOPS Historical review Haemangiopericytoma (HPC) first described primarily as a soft tissue vascular tumour of pericytic

More information

Medical Affairs Policy

Medical Affairs Policy Medical Affairs Policy Service: PET Scan (Positron Emission Tomography) PUM 250-0010 Arise/WPS Policy Committee Approval 03/11/16 Effective Date 07/01/16 Prior Authorization Needed Yes Disclaimer: This

More information

Proton Therapy: Cutting Edge Treatment for Cancerous Tumors. By: Cherilyn G. Murer, JD, CRA

Proton Therapy: Cutting Edge Treatment for Cancerous Tumors. By: Cherilyn G. Murer, JD, CRA Proton Therapy: Cutting Edge Treatment for Cancerous Tumors By: Cherilyn G. Murer, JD, CRA Introduction Put simply, proton therapy is a new cutting edge cancer treatment that promises better outcomes for

More information

National Cancer Institute Research on Childhood Cancers. In the United States in 2005, approximately 9,510 children under age 15 will be

National Cancer Institute Research on Childhood Cancers. In the United States in 2005, approximately 9,510 children under age 15 will be CANCER FACTS N a t i o n a l C a n c e r I n s t i t u t e N a t i o n a l I n s t i t u t e s o f H e a l t h D e p a r t m e n t o f H e a l t h a n d H u m a n S e r v i c e s National Cancer Institute

More information

Part II: NCCN Practice Guidelines Narrative Summary PET and PET/CT

Part II: NCCN Practice Guidelines Narrative Summary PET and PET/CT Part II: NCCN Practice Guidelines Narrative Summary PET and PET/CT NCCN guidelines were reviewed on 3/25/2013 for utilization of 18 F-fluorodeoxyglucose (FDG) PET and PET/CT (available at: http://www.nccn.org/professionals/physician_gls/f_guidelines.asp).

More information

The Diagnosis of Cancer in the Pathology Laboratory

The Diagnosis of Cancer in the Pathology Laboratory The Diagnosis of Cancer in the Pathology Laboratory Dr Edward Sheffield Christmas Select 74 Meeting, Queen s Hotel Cheltenham, 3 rd December 2014 Agenda Overview of the pathology of cancer How specimens

More information

Farmacologia Chemioterapia_2

Farmacologia Chemioterapia_2 Farmacologia Chemioterapia_2 Principles of Cancer Treatment The goal of cancer treatment is first to eradicate the cancer. If this primary goal cannot be accomplished, the goal of cancer treatment shifts

More information

Information Services Division NHS National Services Scotland

Information Services Division NHS National Services Scotland Cancer in Scotland April 2014 First published in June 2004, revised with each National Statistics publication Next due for revision October 2014 Information Services Division NHS National Services Scotland

More information

659 Heart: 1 Atrial myxoma 1. Artery: 5 Normal 5. Vein: 1 Leiomyosarcoma well-differentiated (inferior vena cava) 1

659 Heart: 1 Atrial myxoma 1. Artery: 5 Normal 5. Vein: 1 Leiomyosarcoma well-differentiated (inferior vena cava) 1 Stony Brook BioBank Specimen Collection (updated 2//6) Site Diagnosis Cardiovascular System 659 Heart: Atrial myxoma Artery: 5 Normal 5 Blood: 652 Vein: Leiomyosarcoma well-differentiated (inferior vena

More information

Medical Review Guidelines Magnetic Resonance Imaging Spine and Spinal Canal

Medical Review Guidelines Magnetic Resonance Imaging Spine and Spinal Canal Medical Guideline Number: MRG2001-04 Effective Date: 2/13/01 Reviewed Date: 1/29/03 Reviewed Date: 6/1/2005 Revised Effective Date: 1/1/2008 Medical Review Guidelines Magnetic Resonance Imaging Spine and

More information

Leukemias and Lymphomas: A primer

Leukemias and Lymphomas: A primer Leukemias and Lymphomas: A primer Normal blood contains circulating white blood cells, red blood cells and platelets 700 red cells (oxygen) 1 white cell Neutrophils (60%) bacterial infection Lymphocytes

More information

Childhood cancer epidemiology in North America. Logan G. Spector, Ph.D. University of Minnesota

Childhood cancer epidemiology in North America. Logan G. Spector, Ph.D. University of Minnesota 1 Childhood cancer epidemiology in North America Logan G. Spector, Ph.D. University of Minnesota Overview 2 Descriptive epidemiology Etiology and natural history Burden of childhood cancer in the US 3

More information

Georgia Childhood Cancer Report 2014

Georgia Childhood Cancer Report 2014 Georgia Childhood Cancer Report 2014 Acknowledgments The authors of this report would like to thank the following for their contribution and assistance in planning and review: Georgia Department of Public

More information

Table 2.2. Cohort studies of consumption of alcoholic beverages and cancer in special populations

Table 2.2. Cohort studies of consumption of alcoholic beverages and cancer in special populations North America Canada Canadian 1951 Schmidt & Popham (1981) 1951 70 9 889 alcoholic men, aged 15 years, admitted to the clinical service of the Addiction Research Foundation of Ontario between Death records

More information

ONCOLOGIC PET ICD-9 CODES

ONCOLOGIC PET ICD-9 CODES ONCOLOGIC PET ICD-9 CODES Solitary Pulmonary Nodule: Assess Likelihood of Malignancy (G0125) Lung Cancer: Diagnosis (G0210) Lung Cancer: Initial Staging (G0211) Lung Cancer: Restaging (G0212) 793.1 Coin

More information

The effect of the introduction of ICD-10 on cancer mortality trends in England and Wales

The effect of the introduction of ICD-10 on cancer mortality trends in England and Wales The effect of the introduction of ICD-10 on cancer mortality trends in Anita Brock, Clare Griffiths and Cleo Rooney, Offi ce for INTRODUCTION From January 2001 deaths in have been coded to the Tenth Revision

More information

Lung Cancer: More than meets the eye

Lung Cancer: More than meets the eye Lung Cancer Education Program November 23, 2013 Lung Cancer: More than meets the eye Shantanu Banerji MD, FRCPC Presenter Disclosure Faculty: Shantanu Banerji Relationships with commercial interests: Grants/Research

More information

$20 million. $3,000,000 Jennifer Goodman Linn Laboratory of New Drug Development in Sarcoma and Rare Cancers $1,000,000 $1,000,000

$20 million. $3,000,000 Jennifer Goodman Linn Laboratory of New Drug Development in Sarcoma and Rare Cancers $1,000,000 $1,000,000 Our 2014 Impact Funding Allocations Cycle for Survival funds promise: Our donations launch and accelerate research studies and clinical trials that drive discovery. By helping fill the funding gap in rare

More information

C a nc e r C e nter. Annual Registry Report

C a nc e r C e nter. Annual Registry Report C a nc e r C e nter Annual Registry Report 214 214 Cancer Registry Report Larraine A. Tooker, CTR Please note that the 214 Cancer Registry Annual Report is created in 214, but it reflects data on cases

More information

Clinical Policy Bulletin: Temozolomide (Temodar)

Clinical Policy Bulletin: Temozolomide (Temodar) Temozolomide (Temodar) Page 1 of 5 Clinical Policy Bulletin: Temozolomide (Temodar) Number: 0000 Policy Aetna considers temozolomide (Temodar) injection medically necessary for members who are unable to

More information

National Cancer Intelligence Network Rare and less common cancers. Incidence and Mortality in England, 2010 to 2013

National Cancer Intelligence Network Rare and less common cancers. Incidence and Mortality in England, 2010 to 2013 National Cancer Intelligence Network Rare and less common cancers Incidence and Mortality in England, 2010 to 2013 About Public Health England Public Health England exists to protect and improve the nation's

More information

Metastatic Cancer: Questions and Answers. Key Points

Metastatic Cancer: Questions and Answers. Key Points CANCER FACTS N a t i o n a l C a n c e r I n s t i t u t e N a t i o n a l I n s t i t u t e s o f H e a l t h D e p a r t m e n t o f H e a l t h a n d H u m a n S e r v i c e s Metastatic Cancer: Questions

More information

Facts about Zurich Claims. Zurich Life Risk

Facts about Zurich Claims. Zurich Life Risk Facts about Zurich Claims Zurich Life Risk A closer look at the claims Income Protection claims sample extract started Cause Occupation Duration (days) Initial monthly benefit Benefits paid to date 23

More information

A23: Oncologic Disease- Tumor Markers

A23: Oncologic Disease- Tumor Markers A23: Oncologic Disease- Tumor Markers Diagnosis Tumor Markers and Genetic Markers Use for Specific Malignancy The following information is from multiple guideline sources as recommendations for use of

More information

A Source of Hard- to- Find Pa3ents and Caregivers For Researchers. Peter Ziedins Peter.ziedins@mpiresearch.ca 514-426- 9295 www.rarepa;entvoice.

A Source of Hard- to- Find Pa3ents and Caregivers For Researchers. Peter Ziedins Peter.ziedins@mpiresearch.ca 514-426- 9295 www.rarepa;entvoice. A Source of Hard- to- Find Pa3ents and Caregivers For Researchers Peter Ziedins Peter.ziedins@mpiresearch.ca 514-426- 9295 www.rarepa;entvoice.com About RPV Rare Pa3ent Voice, LLC was formed to provide

More information

Second Cancers in Adults

Second Cancers in Adults Second Cancers in Adults This document focuses on second cancers in adults. For information about second cancers after treatment of childhood cancers, see our document Children Diagnosed With Cancer: Late

More information

Cancer incidence and mortality in Western Australia, A report of the Western Australian Cancer Registry

Cancer incidence and mortality in Western Australia, A report of the Western Australian Cancer Registry Cancer incidence and mortality in Western Australia, 2010 A report of the Western Australian Cancer Registry Statistical series number 94 ISSN: 0816-2999 AUGUST 2012 Cancer incidence and mortality in

More information

G418 Protocol and Selection Guide

G418 Protocol and Selection Guide G418 Protocol and Selection Guide Background G418 is routinely used in gene selections to screen for resistant mammalian cells which express the neo gene. The neo gene encodes amino-glycoside 3 -phosphotransferase;

More information

(Osteosarcoma; Chondrosarcoma; Ewing s Sarcoma; Fibrosarcoma; Malignant Fibrous Histiocytoma; Primary Lymphoma of Bone; Giant Cell Tumor; Chordoma)

(Osteosarcoma; Chondrosarcoma; Ewing s Sarcoma; Fibrosarcoma; Malignant Fibrous Histiocytoma; Primary Lymphoma of Bone; Giant Cell Tumor; Chordoma) Bone Cancer (Osteosarcoma; Chondrosarcoma; Ewing s Sarcoma; Fibrosarcoma; Malignant Fibrous Histiocytoma; Primary Lymphoma of Bone; Giant Cell Tumor; Chordoma) by Krisha McCoy, MS En Español (Spanish Version)

More information

How CanCer becomes critical in the claims

How CanCer becomes critical in the claims How CanCer becomes critical in the claims arena Cancer is a disease in which cells in your body grow in an uncontrolled way and form a lump called a tumour. In a healthy individual cells grow and reproduce

More information

Understanding the ICD-10-CM Neoplasm Coding Guidelines

Understanding the ICD-10-CM Neoplasm Coding Guidelines Understanding the ICD-10-CM Neoplasm Coding Guidelines Sarah A. Serling, CCS, CPC, CCS-P, CPC-H, CEMC, CPC-I, Approved ICD-10-CM/PCS Trainer October 14, 2015 Objectives In this session we will: Examine

More information

CHAPTER 2. Neoplasms (C00-D49) March 2014. 2014 MVP Health Care, Inc.

CHAPTER 2. Neoplasms (C00-D49) March 2014. 2014 MVP Health Care, Inc. Neoplasms (C00-D49) March 2014 2014 MVP Health Care, Inc. CHAPTER SPECIFIC CATEGORY CODE BLOCKS C00-C14 Malignant neoplasms of lip, oral cavity and pharynx C15-C26 Malignant neoplasms of digestive organs

More information

Estimated New Cases of Leukemia, Lymphoma, Myeloma 2014

Estimated New Cases of Leukemia, Lymphoma, Myeloma 2014 ABOUT BLOOD CANCERS Leukemia, Hodgkin lymphoma (HL), non-hodgkin lymphoma (NHL), myeloma, myelodysplastic syndromes (MDS) and myeloproliferative neoplasms (MPNs) are types of cancer that can affect the

More information

National Pharmaceutical Pricing Authority 3 rd Floor, YMCA Cultural Centre 1 Jai Singh Road New Delhi 110001 File No. 23(01)2014/Div.

National Pharmaceutical Pricing Authority 3 rd Floor, YMCA Cultural Centre 1 Jai Singh Road New Delhi 110001 File No. 23(01)2014/Div. Dated 21 st November 2014 NPPA Invites Comments of Pharmaceutical Industry & Trade, Consumer Organisations, Public Health Experts and other Stakeholders on the Recommendations of Tata Memorial Centre under

More information

Soft tissue sarcoma. 329 Soft tissue sarcoma Page 1 of 11

Soft tissue sarcoma. 329 Soft tissue sarcoma Page 1 of 11 Soft tissue sarcoma Page 1 of 11 Introduction This booklet is to give you, your family and your friends some information about this group of illnesses, and how we treat them at The Christie. Introduction:

More information

Chapter 4 Section 23.1. High Dose Chemotherapy (HDC) And Stem Cell Transplantation

Chapter 4 Section 23.1. High Dose Chemotherapy (HDC) And Stem Cell Transplantation Surgery Chapter 4 Section 23.1 High Dose Chemotherapy (HDC) And Stem Cell Transplantation Issue Date: November 1, 1983 Authority: 32 CFR 199.4(e)(5) and (g)(15) 1.0 CPT 1 PROCEDURE CODES 38205, 38207,

More information

The table below presents the summary of observed geographic variation for incidence and survival by type of cancer and gender.

The table below presents the summary of observed geographic variation for incidence and survival by type of cancer and gender. Results and Maps Overview When disparities in cancer incidence and survival are evident, there are a number of potential explanations, including but not restricted to differences in environmental risk

More information

Diagnostic Slide Session Case Jennifer Ziskin MD, PhD, and Edward D Plowey MD, PhD Stanford University, Stanford, CA

Diagnostic Slide Session Case Jennifer Ziskin MD, PhD, and Edward D Plowey MD, PhD Stanford University, Stanford, CA Diagnostic Slide Session Case 2015-2 Jennifer Ziskin MD, PhD, and Edward D Plowey MD, PhD Stanford University, Stanford, CA Clinical History: 18 year old woman with right facial pain and hyperalgesia Past

More information

Number. Source: Vital Records, M CDPH

Number. Source: Vital Records, M CDPH Epidemiology of Cancer in Department of Public Health Revised April 212 Introduction The general public is very concerned about cancer in the community. Many residents believe that cancer rates are high

More information

Cancer in Northeastern Pennsylvania: Incidence and Mortality of Common Cancers

Cancer in Northeastern Pennsylvania: Incidence and Mortality of Common Cancers Cancer in Northeastern Pennsylvania: Incidence and Mortality of Common Cancers Samuel M. Lesko, MD, MPH Medical Director Karen Ryczak, RN Surveillance Coordinator November 2015 334 Jefferson Avenue, Scranton,

More information

Main Street Planning Group 180 East Main Street Suite 110 Patchogue, NY 11772 Tel: 631.647.4694 Fax: 631.647.4697 MainStreetPlanningGroup.

Main Street Planning Group 180 East Main Street Suite 110 Patchogue, NY 11772 Tel: 631.647.4694 Fax: 631.647.4697 MainStreetPlanningGroup. Main Street Planning Group 180 East Main Street Suite 110 Patchogue, NY 11772 Tel: 631.647.4694 Fax: 631.647.4697 MainStreetPlanningGroup.com Presented by Ted Mageau Ted@MainStreetPlanningGroup.com Life

More information

Biological Therapies for Cancer: Questions and Answers. Key Points

Biological Therapies for Cancer: Questions and Answers. Key Points CANCER FACTS N a t i o n a l C a n c e r I n s t i t u t e N a t i o n a l I n s t i t u t e s o f H e a l t h D e p a r t m e n t o f H e a l t h a n d H u m a n S e r v i c e s Biological Therapies for

More information

at a critical moment Physician Suggestion Line...

at a critical moment Physician Suggestion Line... Radiation Oncology Exceptional care at a critical moment When your patients require radiation therapy, they deserve the very best care available to them. The Department of Radiation Oncology provides exceptional

More information

. Tissue Origin Benign Malignant Reactive Fibrous Fibroma Fibrosarcoma Dupuytrens contracture. Fat cells Lipoma/ Liposarcoma Hibernoma Angiolipoma

. Tissue Origin Benign Malignant Reactive Fibrous Fibroma Fibrosarcoma Dupuytrens contracture. Fat cells Lipoma/ Liposarcoma Hibernoma Angiolipoma SOFT TISSUE TUMOR Advances in Imaging, diagnosis, surgical technique, instrumentation, adjuvant therapy and basic knowledge of tumor biology have decreased disease free survival in a soft tissue sarcoma

More information

Tumour Markers. What are Tumour Markers? How Are Tumour Markers Used?

Tumour Markers. What are Tumour Markers? How Are Tumour Markers Used? Dr. Anthony C.H. YING What are? Tumour markers are substances that can be found in the body when cancer is present. They are usually found in the blood or urine. They can be products of cancer cells or

More information

Foundations of Oncology Nursing Practice

Foundations of Oncology Nursing Practice Foundations of Oncology Nursing Practice Course Syllabus Course Lead:, RN, MN, BScN, CON(C) Associate Faculty:, RN, CON(C) Last updated January 27, 2011 Course Description: This online course will introduce

More information

TREATMENT UPDATE

TREATMENT UPDATE TREATMENT UPDATE WWW.CANCERCARE.ORG The CancerCare Connect Booklet Series offers up-to-date, easy-to-read information on the latest treatments, managing side effects, and coping with cancer. To order free

More information

An analysis of cancer risk experienced by fire fighters who were trained at Fiskville

An analysis of cancer risk experienced by fire fighters who were trained at Fiskville An analysis of cancer risk experienced by fire fighters who were trained at Fiskville Background Cancer Council Victoria was commissioned by CFA to perform an analysis of cancer risk for Country Fire Authority

More information

Cancer Drug Coverage: Putting IV and Orally Administered Drugs on an Equal Footing. Deb Maskens Kidney Cancer Canada

Cancer Drug Coverage: Putting IV and Orally Administered Drugs on an Equal Footing. Deb Maskens Kidney Cancer Canada Cancer Drug Coverage: Putting IV and Orally Administered Drugs on an Equal Footing Deb Maskens Kidney Cancer Canada The Coalition 30+ cancer groups Common issue: IV vs Oral Objective Reimbursement policy

More information

A Publication of the National Registry of Diseases Office, Singapore. Trends of Colorectal Cancer in Singapore,

A Publication of the National Registry of Diseases Office, Singapore. Trends of Colorectal Cancer in Singapore, Health Factsheet February 27, 2013, INP-13-1 A Publication of the National Registry of Diseases Office, Singapore Trends of Colorectal Cancer in Singapore, 2007-2011 1. Introduction The large intestine

More information

HADRON THERAPY FOR CANCER TREATMENT

HADRON THERAPY FOR CANCER TREATMENT HADRON THERAPY FOR CANCER TREATMENT Seminar presented by Arlene Lennox at Fermilab on Nov 21, 2003 CANCER STAGES LOCAL TUMOR REGIONAL METASTASIS SYSTEMIC DISEASE CANCER TREATMENT SURGERY RADIATION THERAPY

More information

AJCC 8 th Edition Staging. Overview. Learning Objectives. This webinar is sponsored by. the Centers for Disease Control and Prevention.

AJCC 8 th Edition Staging. Overview. Learning Objectives. This webinar is sponsored by. the Centers for Disease Control and Prevention. AJCC 8 th Edition Staging Overview Donna M. Gress, RHIT, CTR Technical Editor, AJCC Cancer Staging Manual First Author, Chapter 1: Cancer Staging Principles Validating science. Improving patient care.

More information

Sommaire projets sélectionnés mesure 29: Soutien à la recherche translationnelle

Sommaire projets sélectionnés mesure 29: Soutien à la recherche translationnelle Sommaire projets sélectionnés mesure 29: Soutien à la recherche translationnelle TITLE PROJET NOM HOPITAL Assessment of tumor angiogenesis using PET/CT with 18 F-Galacto- RGD. (PNC_29_001) Division of

More information

3.8 DISABILITY COMPENSATION FOR DISEASES ASSOCIATED WITH AGENT ORANGE AND OTHER HERBICIDES USED IN VIETNAM

3.8 DISABILITY COMPENSATION FOR DISEASES ASSOCIATED WITH AGENT ORANGE AND OTHER HERBICIDES USED IN VIETNAM 3.8 DISABILITY COMPENSATION FOR DISEASES ASSOCIATED WITH AGENT ORANGE AND OTHER HERBICIDES USED IN VIETNAM 3.8.1 The Three Requirements for Disability Compensation Based Upon Agent Orange Exposure 3.8.1.1

More information

Table A: Leading Causes of Death* by Age Group North Carolina Residents, 2015

Table A: Leading Causes of Death* by Age Group North Carolina Residents, 2015 Table A: Leading Causes of Death* by Age Group All Ages 1 Cancer 19,309 2 Diseases of the heart 18,467 3 Chronic lower respiratory diseases 5,221 4 Cerebrovascular disease 5,028 5 Alzheimer's disease 3,803

More information

One (1) single qualifying condition of either HIV/AIDS or a Serious Mental Illness (SMI)

One (1) single qualifying condition of either HIV/AIDS or a Serious Mental Illness (SMI) Eligibility Criteria for Health Home Services: Chronic Conditions New York State s Health Home eligibility criteria is as follows: Medicaid eligible/active Medicaid; and Two (2) or more chronic conditions;

More information